Spots Global Cancer Trial Database for Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow

Official Title: Comparison of Two Types of Intrathecal Morphine Administration by Pump for Analgesia in Cancer Patients With Failure of Conventional Analgesic Therapy.

Study ID: NCT01567345

Conditions

Advanced Cancer

Intractable Pain

Interventions

Implantable pump with continuous flow

Implantable pump with programmable flow.

Study Description

Brief Summary: The aim of this study is to compare intrathecal morphine administration: using a pump with continuous or programmable flow.

Detailed Description: Cancer is frequently associated with pain. In spite of recent improvements in cancer related pain treatment, incidence of cancerous chronic pain did not decrease. Indeed, 15 to 20% of patients are still suffering from intractable pain despite an optimal symptom management. Treatment of cancer pain is generally based on the WHO analgesic ladder according to 3 steps. Patients with advanced cancer are often treated at WHO step 3 analgesics, i.e. morphine and its derivatives, at high dosages. But increasing the dosage of opioids also leads to accentuation of their adverse events and the corresponding risks. At this stage of the disease, in patients with failure of conventional analgesic therapy, intrathecal injection of analgesics can be decided in order to relieve pain. 2 types of pumps allow intrathecal morphine administration : continuous or programmable flow. In this study, we want to compare the quality of analgesia obtained through these 2 flows.